Palladini G - Search Results

1

Daratumumab-Based Treatment for Immunoglobulin Light-Chain Amyloidosis.

Kastritis E, Palladini G, Minnema MC, Wechalekar AD, Jaccard A, Lee HC, Sanchorawala V, Gibbs S, Mollee P, Venner CP, Lu J, Schönland S, Gatt ME, Suzuki K, Kim K, Cibeira MT, Beksac M, Libby E, Valent J, Hungria V, Wong SW, Rosenzweig M, Bumma N, Huart A, Dimopoulos MA, Bhutani D, Waxman AJ, Goodman SA, Zonder JA, Lam S, Song K, Hansen T, Manier S, Roeloffzen W, Jamroziak K, Kwok F, Shimazaki C, Kim JS, Crusoe E, Ahmadi T, Tran N, Qin X, Vasey SY, Tromp B, Schecter JM, Weiss BM, Zhuang SH, Vermeulen J, Merlini G, Comenzo RL; ANDROMEDA Trial Investigators. Kastritis E, et al. Among authors: palladini g. N Engl J Med. 2021 Jul 1;385(1):46-58. doi: 10.1056/NEJMoa2028631. N Engl J Med. 2021. PMID: 34192431 Clinical Trial.

2

Abnormalities in thrombin-antithrombin pathway in AL amyloidosis.

Gamba G, Montani N, Anesi E, Palladini G, Lorenzutti F, Perfetti V, Merlini G. Gamba G, et al. Among authors: palladini g. Amyloid. 1999 Dec;6(4):273-7. doi: 10.3109/13506129909007339. Amyloid. 1999. PMID: 10611948

3

Clotting alterations in primary systemic amyloidosis.

Gamba G, Montani N, Anesi E, Palladini G, Capezzera M, Soldavini E, Merlini G. Gamba G, et al. Among authors: palladini g. Haematologica. 2000 Mar;85(3):289-92. Haematologica. 2000. PMID: 10702818

4

A modified high-dose dexamethasone regimen for primary systemic (AL) amyloidosis.

Palladini G, Anesi E, Perfetti V, Obici L, Invernizzi R, Balduini C, Ascari E, Merlini G. Palladini G, et al. Br J Haematol. 2001 Jun;113(4):1044-6. doi: 10.1046/j.1365-2141.2001.02859.x. Br J Haematol. 2001. PMID: 11442500 Free article.

5

Protein aggregation.

Merlini G, Bellotti V, Andreola A, Palladini G, Obici L, Casarini S, Perfetti V. Merlini G, et al. Among authors: palladini g. Clin Chem Lab Med. 2001 Nov;39(11):1065-75. doi: 10.1515/CCLM.2001.172. Clin Chem Lab Med. 2001. PMID: 11831622

6

A multicenter phase II trial of 4'-iodo-4'deoxydoxorubicin (IDOX) in primary amyloidosis (AL).

Gertz MA, Lacy MQ, Dispenzieri A, Cheson BD, Barlogie B, Kyle RA, Palladini G, Geyer SM, Merlini G. Gertz MA, et al. Among authors: palladini g. Amyloid. 2002 Mar;9(1):24-30. doi: 10.3109/13506120209072441. Amyloid. 2002. PMID: 12000194 Clinical Trial.

7

Analysis of V(lambda)-J(lambda) expression in plasma cells from primary (AL) amyloidosis and normal bone marrow identifies 3r (lambdaIII) as a new amyloid-associated germline gene segment.

Perfetti V, Casarini S, Palladini G, Vignarelli MC, Klersy C, Diegoli M, Ascari E, Merlini G. Perfetti V, et al. Among authors: palladini g. Blood. 2002 Aug 1;100(3):948-53. doi: 10.1182/blood-2002-01-0114. Blood. 2002. PMID: 12130507 Free article.

8

Hereditary amyloidosis.

Palladini G, Obici L, Merlini G. Palladini G, et al. N Engl J Med. 2002 Oct 10;347(15):1206-7; author reply 1206-7. doi: 10.1056/NEJM200210103471517. N Engl J Med. 2002. PMID: 12374886 No abstract available.

9

Serum N-terminal pro-brain natriuretic peptide is a sensitive marker of myocardial dysfunction in AL amyloidosis.

Palladini G, Campana C, Klersy C, Balduini A, Vadacca G, Perfetti V, Perlini S, Obici L, Ascari E, d'Eril GM, Moratti R, Merlini G. Palladini G, et al. Circulation. 2003 May 20;107(19):2440-5. doi: 10.1161/01.CIR.0000068314.02595.B2. Epub 2003 Apr 28. Circulation. 2003. PMID: 12719281 Free article. Clinical Trial.

10

Prognostic factors in symptomatic Waldenstrom's macroglobulinemia.

Merlini G, Baldini L, Broglia C, Comelli M, Goldaniga M, Palladini G, Deliliers GL, Gobbi PG. Merlini G, et al. Among authors: palladini g. Semin Oncol. 2003 Apr;30(2):211-5. doi: 10.1053/sonc.2003.50064. Semin Oncol. 2003. PMID: 12720138

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

407 results

Search Page